KMD Biomarker Diagnostics Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

KMD Biomarker Diagnostics General Information

Description

Developer of a malignancy test kit designed to analyze metabolic profiles for early-detection of breast cancer. The company's diagnostics testing kit uses metabolomics and biomarker analytics to find the combination of metabolites produced by abnormal cells in a given sample of urine and sends signals detecting the presence of malignant cells, enabling physicians to detect breast cancer non-invasively, cost effectively and painlessly.

Contact Information

Website
www.kmdbio.com
Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Biotechnology
Primary Office
  • 202 North 9th Street
  • Boise, ID 83702
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KMD Biomarker Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Product Crowdfunding 01-Jan-2015 00.000 Completed Startup
To view KMD Biomarker Diagnostics’s complete valuation and funding history, request access »

KMD Biomarker Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Nick Kaludov Ph.D Co-Founder
Dejan Nenov Co-Founder & Chief Executive Officer
Martin Martinov Ph.D Co-Founder
To view KMD Biomarker Diagnostics’s complete executive team members history, request access »